Annovis Bio appoints Mark Guerin as CFO; base salary $450K plus options for 200K shares

Annovis Bio, Inc.

Mark Guerin appointed CFO effective Sept 25, 2025; previously CFO of Onconova/Traws Pharma (TRAW).
Compensation: $450K base salary, 40% annual target bonus, options for 200,000 shares, six months severance.
Guerin holds CPA, CMA, CFM certifications; began career at Coopers & Lybrand.
No transactions requiring disclosure under Item 404(a) between Guerin and the Company.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.